[{"address1": "Clarence Thomas Building", "address2": "P.O. Box 4649 Road Town", "city": "Tortola", "zip": "VG1110", "country": "British Virgin Islands", "phone": "203 221 7378", "website": "https://www.portagebiotech.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. Its product pipeline comprises PORT-8, a dual inhibitor of adenosine receptors 2A and 2B, which is in preclinical trial to treat solid tumors; PORT-9, an A2B antagonist, which is in pre-clinical stage program to treat colorectal and gastrointestinal cancers; and PORT-3, a polylactide-co-glycolide, which is in phase 1 to treat NY-ESO-1 positive tumors. The company also develops PORT-4, a nanolipogel co-formulations to treat of solid tumors that is in preclinical trials; and PORT-5, a VLP-STING to treat of solid tumors and is in preclinical trials. Portage Biotech Inc. is based in Tortola, British Virgin Islands.", "fullTimeEmployees": 7, "companyOfficers": [{"maxAge": 1, "name": "Dr. Robert A. Kramer Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2024, "totalPay": 185891, "exercisedValue": 0, "unexercisedValue": 128769}, {"maxAge": 1, "name": "Mr. Alexander  Pickett", "title": "CEO & Director", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Eun-Jae  Park CPA", "age": 52, "title": "Chief Financial Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Adam  Melero", "title": "Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter  Molloy", "title": "Chief Executive Officer of Cyncado Therapeutics Inc.", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 8.25, "open": 8.085, "dayLow": 7.7815, "dayHigh": 8.22, "regularMarketPreviousClose": 8.25, "regularMarketOpen": 8.085, "regularMarketDayLow": 7.7815, "regularMarketDayHigh": 8.22, "payoutRatio": 0.0, "beta": 0.837, "forwardPE": -15.173078, "volume": 9426, "regularMarketVolume": 9426, "averageVolume": 1345655, "averageVolume10days": 33360, "averageDailyVolume10Day": 33360, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 12982600, "fiftyTwoWeekLow": 2.1, "fiftyTwoWeekHigh": 23.01, "fiftyDayAverage": 7.45878, "twoHundredDayAverage": 5.50162, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 6406155, "profitMargins": 0.0, "floatShares": 551729, "sharesOutstanding": 1645450, "sharesShort": 114380, "sharesShortPriorMonth": 308412, "sharesShortPreviousMonthDate": 1743379200, "dateShortInterest": 1745971200, "sharesPercentSharesOut": 0.0695, "heldPercentInsiders": 0.51378, "heldPercentInstitutions": 0.06434, "shortRatio": 0.05, "shortPercentOfFloat": 0.087799996, "impliedSharesOutstanding": 1645450, "bookValue": 1.252, "priceToBook": 6.301917, "lastFiscalYearEnd": 1711843200, "nextFiscalYearEnd": 1743379200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -67278000, "trailingEps": -68.17, "forwardEps": -0.52, "lastSplitFactor": "1:20", "lastSplitDate": 1723680000, "enterpriseToEbitda": -0.547, "52WeekChange": 0.4503677, "SandP52WeekChange": 0.09362543, "quoteType": "EQUITY", "currentPrice": 7.89, "recommendationKey": "none", "totalCash": 1764000, "totalCashPerShare": 1.574, "ebitda": -11715000, "totalDebt": 28000, "quickRatio": 2.674, "currentRatio": 3.077, "debtToEquity": 4.029, "returnOnAssets": -0.15454, "returnOnEquity": -1.98892, "freeCashflow": -6307750, "operatingCashflow": -9798000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PRTG", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1748041683, "regularMarketTime": 1748030400, "exchange": "NCM", "messageBoardId": "finmb_233586353", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -4.363638, "regularMarketPrice": 7.89, "shortName": "Portage Biotech Inc.", "longName": "Portage Biotech Inc.", "postMarketChangePercent": 3.29531, "postMarketPrice": 8.15, "postMarketChange": 0.26, "regularMarketChange": -0.36000013, "regularMarketDayRange": "7.7815 - 8.22", "fullExchangeName": "NasdaqCM", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1009981800000, "averageDailyVolume3Month": 1345655, "fiftyTwoWeekLowChange": 5.79, "fiftyTwoWeekLowChangePercent": 2.757143, "fiftyTwoWeekRange": "2.1 - 23.01", "fiftyTwoWeekHighChange": -15.120001, "fiftyTwoWeekHighChangePercent": -0.6571056, "fiftyTwoWeekChangePercent": 45.03677, "dividendDate": 1591228800, "earningsTimestampStart": 1748602740, "earningsTimestampEnd": 1749038400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -68.17, "epsForward": -0.52, "fiftyDayAverageChange": 0.43122005, "fiftyDayAverageChangePercent": 0.057813752, "twoHundredDayAverageChange": 2.38838, "twoHundredDayAverageChangePercent": 0.43412307, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-02-25", "cryptoTradeable": false, "displayName": "Portage Biotech", "trailingPegRatio": null, "__fetch_time": "2025-05-24"}]